APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Interleukin 17A

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Interleukin 17A Industry Growth and Trends Forecast to 2032

26 December 202592 pages

Choose your research edition.

Industry ResearchInterleukin 17A Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Interleukin 17A Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Interleukin 17A Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Interleukin 17A Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Interleukin 17A Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Interleukin 17A market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Interleukin 17A is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Interleukin 17A is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Interleukin 17A is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Interleukin 17A include Abeome Corporation, Affibody AB, Cell Medica Limited, Orega Biotech SAS, AbbVie Inc, Eli Lilly and Company, Merck KGaA, Novartis AG and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Interleukin 17A market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Interleukin 17A market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Interleukin 17A market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Interleukin 17A.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Interleukin 17A market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Interleukin 17A Market by Company

Abeome Corporation

Affibody AB

Cell Medica Limited

Orega Biotech SAS

AbbVie Inc

Eli Lilly and Company

Merck KGaA

Novartis AG

Johnson & Johnson

Interleukin 17A Segment by Type

DLX-2882

CNTO-6785

ABY-035

Others

Interleukin 17A Segment by Application

Kidney Cancer

Chronic Pain

Liver Cancer

Others

Interleukin 17A Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Interleukin 17A market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Interleukin 17A and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Interleukin 17A.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Interleukin 17A manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Interleukin 17A in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of DLX-2882 Table 2. Major Company of CNTO-6785 Table 3. Major Company of ABY-035 Table 4. Major Company of Others Table 5. Global Interleukin 17A Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Interleukin 17A Sales by Type (2021-2026) & (W Units) Table 7. Global Interleukin 17A Sales Market Share in Volume by Type (2021-2026) Table 8. Global Interleukin 17A Sales by Type (2021-2026) & (US$ Million) Table 9. Global Interleukin 17A Sales Market Share in Value by Type (2021-2026) Table 10. Global Interleukin 17A Price by Type (2021-2026) & (US$/Unit) Table 11. Global Interleukin 17A Sales by Type (2027-2032) & (W Units) Table 12. Global Interleukin 17A Sales Market Share in Volume by Type (2027-2032) Table 13. Global Interleukin 17A Sales by Type (2027-2032) & (US$ Million) Table 14. Global Interleukin 17A Sales Market Share in Value by Type (2027-2032) Table 15. Global Interleukin 17A Price by Type (2027-2032) & (US$/Unit) Table 16. North America Interleukin 17A Sales by Type (2021-2026) & (W Units) Table 17. North America Interleukin 17A Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Interleukin 17A Sales by Type (2021-2026) & (W Units) Table 19. Europe Interleukin 17A Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Interleukin 17A Sales by Type (2021-2026) & (W Units) Table 21. Asia-Pacific Interleukin 17A Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Interleukin 17A Sales by Type (2021-2026) & (W Units) Table 23. Latin America Interleukin 17A Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Interleukin 17A Sales by Type (2021-2026) & (W Units) Table 25. Middle East and Africa Interleukin 17A Sales by Type (2021-2026) & (US$ Million) Table 26. Interleukin 17A Industry Trends Table 27. Interleukin 17A Industry Drivers Table 28. Interleukin 17A Industry Opportunities and Challenges Table 29. Interleukin 17A Industry Restraints Table 30. Global Interleukin 17A Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Interleukin 17A Revenue Market Share by Company (2021-2026) Table 32. Global Interleukin 17A Sales by Company (2021-2026) & (W Units) Table 33. Global Interleukin 17A Sales Share by Company (2021-2026) Table 34. Global Interleukin 17A Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Interleukin 17A Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Interleukin 17A Major Company Production Sites and Headquarters Table 37. Global Interleukin 17A Company, Product Type & Application Table 38. Global Interleukin 17A Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Interleukin 17A by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Interleukin 17A Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Interleukin 17A Sales by Region (2021-2026) & (W Units) Table 43. Global Interleukin 17A Sales Market Share in Volume by Region (2021-2026) Table 44. Global Interleukin 17A Sales by Region (2021-2026) & (US$ Million) Table 45. Global Interleukin 17A Sales Market Share in Value by Region (2021-2026) Table 46. Global Interleukin 17A Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Interleukin 17A Sales by Region (2027-2032) & (W Units) Table 48. Global Interleukin 17A Sales Market Share in Volume by Region (2027-2032) Table 49. Global Interleukin 17A Sales by Region (2027-2032) & (US$ Million) Table 50. Global Interleukin 17A Sales Market Share in Value by Region (2027-2032) Table 51. Global Interleukin 17A Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Interleukin 17A Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Interleukin 17A Sales by Application (2021-2026) & (W Units) Table 54. Global Interleukin 17A Sales Market Share in Volume by Application (2021-2026) Table 55. Global Interleukin 17A Sales by Application (2021-2026) & (US$ Million) Table 56. Global Interleukin 17A Sales Market Share in Value by Application (2021-2026) Table 57. Global Interleukin 17A Price by Application (2021-2026) & (US$/Unit) Table 58. Global Interleukin 17A Sales by Application (2027-2032) & (W Units) Table 59. Global Interleukin 17A Sales Market Share in Volume by Application (2027-2032) Table 60. Global Interleukin 17A Sales by Application (2027-2032) & (US$ Million) Table 61. Global Interleukin 17A Sales Market Share in Value by Application (2027-2032) Table 62. Global Interleukin 17A Price by Application (2027-2032) & (US$/Unit) Table 63. North America Interleukin 17A Sales by Application (2021-2026) & (W Units) Table 64. North America Interleukin 17A Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Interleukin 17A Sales by Application (2021-2026) & (W Units) Table 66. Europe Interleukin 17A Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Interleukin 17A Sales by Application (2021-2026) & (W Units) Table 68. Asia-Pacific Interleukin 17A Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Interleukin 17A Sales by Application (2021-2026) & (W Units) Table 70. Latin America Interleukin 17A Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Interleukin 17A Sales by Application (2021-2026) & (W Units) Table 72. Middle East and Africa Interleukin 17A Sales by Application (2021-2026) & (US$ Million) Table 73. Abeome Corporation Company Information Table 74. Abeome Corporation Business Overview Table 75. Abeome Corporation Interleukin 17A Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Abeome Corporation Interleukin 17A Product Portfolio Table 77. Abeome Corporation Recent Development Table 78. Affibody AB Company Information Table 79. Affibody AB Business Overview Table 80. Affibody AB Interleukin 17A Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Affibody AB Interleukin 17A Product Portfolio Table 82. Affibody AB Recent Development Table 83. Cell Medica Limited Company Information Table 84. Cell Medica Limited Business Overview Table 85. Cell Medica Limited Interleukin 17A Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Cell Medica Limited Interleukin 17A Product Portfolio Table 87. Cell Medica Limited Recent Development Table 88. Orega Biotech SAS Company Information Table 89. Orega Biotech SAS Business Overview Table 90. Orega Biotech SAS Interleukin 17A Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Orega Biotech SAS Interleukin 17A Product Portfolio Table 92. Orega Biotech SAS Recent Development Table 93. AbbVie Inc Company Information Table 94. AbbVie Inc Business Overview Table 95. AbbVie Inc Interleukin 17A Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. AbbVie Inc Interleukin 17A Product Portfolio Table 97. AbbVie Inc Recent Development Table 98. Eli Lilly and Company Company Information Table 99. Eli Lilly and Company Business Overview Table 100. Eli Lilly and Company Interleukin 17A Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Eli Lilly and Company Interleukin 17A Product Portfolio Table 102. Eli Lilly and Company Recent Development Table 103. Merck KGaA Company Information Table 104. Merck KGaA Business Overview Table 105. Merck KGaA Interleukin 17A Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Merck KGaA Interleukin 17A Product Portfolio Table 107. Merck KGaA Recent Development Table 108. Novartis AG Company Information Table 109. Novartis AG Business Overview Table 110. Novartis AG Interleukin 17A Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Novartis AG Interleukin 17A Product Portfolio Table 112. Novartis AG Recent Development Table 113. Johnson & Johnson Company Information Table 114. Johnson & Johnson Business Overview Table 115. Johnson & Johnson Interleukin 17A Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Johnson & Johnson Interleukin 17A Product Portfolio Table 117. Johnson & Johnson Recent Development Table 118. North America Interleukin 17A Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 119. North America Interleukin 17A Sales by Country (2021-2026) & (W Units) Table 120. North America Interleukin 17A Sales Market Share by Country (2021-2026) Table 121. North America Interleukin 17A Sales Forecast by Country (2027-2032) & (W Units) Table 122. North America Interleukin 17A Sales Market Share Forecast by Country (2027-2032) Table 123. North America Interleukin 17A Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Interleukin 17A Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Interleukin 17A Market Share by Country (2021-2026) Table 126. North America Interleukin 17A Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Interleukin 17A Market Share Forecast by Country (2027-2032) Table 128. Europe Interleukin 17A Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 129. Europe Interleukin 17A Sales by Country (2021-2026) & (W Units) Table 130. Europe Interleukin 17A Sales Market Share by Country (2021-2026) Table 131. Europe Interleukin 17A Sales Forecast by Country (2027-2032) & (W Units) Table 132. Europe Interleukin 17A Sales Market Share Forecast by Country (2027-2032) Table 133. Europe Interleukin 17A Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Interleukin 17A Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Interleukin 17A Market Share by Country (2021-2026) Table 136. Europe Interleukin 17A Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Interleukin 17A Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Interleukin 17A Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Interleukin 17A Sales by Country (2021-2026) & (W Units) Table 140. Asia-Pacific Interleukin 17A Sales Market Share by Country (2021-2026) Table 141. Asia-Pacific Interleukin 17A Sales Forecast by Country (2027-2032) & (W Units) Table 142. Asia-Pacific Interleukin 17A Sales Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Interleukin 17A Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Interleukin 17A Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Interleukin 17A Market Share by Country (2021-2026) Table 146. Asia-Pacific Interleukin 17A Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Interleukin 17A Market Share Forecast by Country (2027-2032) Table 148. Latin America Interleukin 17A Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 149. Latin America Interleukin 17A Sales by Country (2021-2026) & (W Units) Table 150. Latin America Interleukin 17A Sales Market Share by Country (2021-2026) Table 151. Latin America Interleukin 17A Sales Forecast by Country (2027-2032) & (W Units) Table 152. Latin America Interleukin 17A Sales Market Share Forecast by Country (2027-2032) Table 153. Latin America Interleukin 17A Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Interleukin 17A Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Interleukin 17A Market Share by Country (2021-2026) Table 156. Latin America Interleukin 17A Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Interleukin 17A Market Share Forecast by Country (2027-2032) Table 158. Middle East and Africa Interleukin 17A Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 159. Middle East and Africa Interleukin 17A Sales by Country (2021-2026) & (W Units) Table 160. Middle East and Africa Interleukin 17A Sales Market Share by Country (2021-2026) Table 161. Middle East and Africa Interleukin 17A Sales Forecast by Country (2027-2032) & (W Units) Table 162. Middle East and Africa Interleukin 17A Sales Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Interleukin 17A Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Interleukin 17A Market Size by Country (2021-2026) & (US$ Million) Table 165. Middle East and Africa Interleukin 17A Market Share by Country (2021-2026) Table 166. Middle East and Africa Interleukin 17A Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Middle East and Africa Interleukin 17A Market Share Forecast by Country (2027-2032) Table 168. Key Raw Materials Table 169. Raw Materials Key Suppliers Table 170. Interleukin 17A Distributors List Table 171. Interleukin 17A Customers List Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Interleukin 17A Image Figure 2. Global Interleukin 17A Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Interleukin 17A Market Size (2021-2032) & (US$ Million) Figure 4. Global Interleukin 17A Sales (2021-2032) & (W Units) Figure 5. DLX-2882 Image Figure 6. Global DLX-2882 Sales YoY Growth (2021-2032) & (W Units) Figure 7. CNTO-6785 Image Figure 8. Global CNTO-6785 Sales YoY Growth (2021-2032) & (W Units) Figure 9. ABY-035 Image Figure 10. Global ABY-035 Sales YoY Growth (2021-2032) & (W Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 13. Global Interleukin 17A Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Interleukin 17A Market Share by Type 2025 VS 2032 Figure 15. North America Interleukin 17A Sales Market Share in Volume by Type in 2025 Figure 16. North America Interleukin 17A Sales Market Share in Value by Type in 2025 Figure 17. Europe Interleukin 17A Sales Market Share in Volume by Type in 2025 Figure 18. Europe Interleukin 17A Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Interleukin 17A Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Interleukin 17A Sales Market Share in Value by Type in 2025 Figure 21. Latin America Interleukin 17A Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Interleukin 17A Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Interleukin 17A Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Interleukin 17A Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Interleukin 17A Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Kidney Cancer Image Figure 28. Global Kidney Cancer Sales YoY Growth (2021-2032) & (W Units) Figure 29. Chronic Pain Image Figure 30. Global Chronic Pain Sales YoY Growth (2021-2032) & (W Units) Figure 31. Liver Cancer Image Figure 32. Global Liver Cancer Sales YoY Growth (2021-2032) & (W Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 35. Global Interleukin 17A Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Interleukin 17A Market Share by Application 2025 VS 2032 Figure 37. North America Interleukin 17A Sales Market Share in Volume by Application in 2025 Figure 38. North America Interleukin 17A Sales Market Share in Value by Application in 2025 Figure 39. Europe Interleukin 17A Sales Market Share in Volume by Application in 2025 Figure 40. Europe Interleukin 17A Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Interleukin 17A Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Interleukin 17A Sales Market Share in Value by Application in 2025 Figure 43. Latin America Interleukin 17A Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Interleukin 17A Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Interleukin 17A Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Interleukin 17A Sales Market Share in Value by Application in 2025 Figure 47. North America Interleukin 17A Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. North America Interleukin 17A Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Interleukin 17A Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Interleukin 17A Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Interleukin 17A Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Europe Interleukin 17A Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Interleukin 17A Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Interleukin 17A Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Interleukin 17A Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Asia-Pacific Interleukin 17A Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Interleukin 17A Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Interleukin 17A Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Interleukin 17A Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Latin America Interleukin 17A Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Interleukin 17A Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Interleukin 17A Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Interleukin 17A Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 64. Middle East and Africa Interleukin 17A Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Interleukin 17A Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Interleukin 17A Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Interleukin 17A Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Interleukin 17A Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • DLX-2882
  • CNTO-6785
  • ABY-035
  • Others
Applications
  • Kidney Cancer
  • Chronic Pain
  • Liver Cancer
  • Others
Companies covered
  • Abeome Corporation
  • Affibody AB
  • Cell Medica Limited
  • Orega Biotech SAS
  • AbbVie Inc
  • Eli Lilly and Company
  • Merck KGaA
  • Novartis AG
  • Johnson & Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Interleukin 17A Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Interleukin 17A Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Interleukin 17A Market by Type
  6. 1.3.1 DLX-2882
  7. 1.3.2 CNTO-6785
  8. 1.3.3 ABY-035
  9. 1.3.4 Others
  10. 1.4 Global Interleukin 17A Market Size by Type
  11. 1.4.1 Global Interleukin 17A Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Interleukin 17A Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Interleukin 17A Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Interleukin 17A Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Interleukin 17A Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Interleukin 17A Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Interleukin 17A Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Interleukin 17A Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Interleukin 17A Industry Trends
  2. 2.2 Interleukin 17A Industry Drivers
  3. 2.3 Interleukin 17A Industry Opportunities and Challenges
  4. 2.4 Interleukin 17A Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Interleukin 17A Revenue (2021-2026)
  2. 3.2 Global Top Players by Interleukin 17A Sales (2021-2026)
  3. 3.3 Global Top Players by Interleukin 17A Price (2021-2026)
  4. 3.4 Global Interleukin 17A Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Interleukin 17A Major Company Production Sites & Headquarters
  6. 3.6 Global Interleukin 17A Company, Product Type & Application
  7. 3.7 Global Interleukin 17A Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Interleukin 17A Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Interleukin 17A Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Interleukin 17A Tier 1, Tier 2, and Tier 3
4 Interleukin 17A Regional Status and Outlook
  1. 4.1 Global Interleukin 17A Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Interleukin 17A Historic Market Size by Region
  3. 4.2.1 Global Interleukin 17A Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Interleukin 17A Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Interleukin 17A Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Interleukin 17A Forecasted Market Size by Region
  7. 4.3.1 Global Interleukin 17A Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Interleukin 17A Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Interleukin 17A Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Interleukin 17A by Application
  1. 5.1 Interleukin 17A Market by Application
  2. 5.1.1 Kidney Cancer
  3. 5.1.2 Chronic Pain
  4. 5.1.3 Liver Cancer
  5. 5.1.4 Others
  6. 5.2 Global Interleukin 17A Market Size by Application
  7. 5.2.1 Global Interleukin 17A Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Interleukin 17A Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Interleukin 17A Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Interleukin 17A Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Interleukin 17A Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Interleukin 17A Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Interleukin 17A Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Interleukin 17A Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Abeome Corporation
  2. 6.1.1 Abeome Corporation Company Information
  3. 6.1.2 Abeome Corporation Business Overview
  4. 6.1.3 Abeome Corporation Interleukin 17A Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Abeome Corporation Interleukin 17A Product Portfolio
  6. 6.1.5 Abeome Corporation Recent Developments
  7. 6.2 Affibody AB
  8. 6.2.1 Affibody AB Company Information
  9. 6.2.2 Affibody AB Business Overview
  10. 6.2.3 Affibody AB Interleukin 17A Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Affibody AB Interleukin 17A Product Portfolio
  12. 6.2.5 Affibody AB Recent Developments
  13. 6.3 Cell Medica Limited
  14. 6.3.1 Cell Medica Limited Company Information
  15. 6.3.2 Cell Medica Limited Business Overview
  16. 6.3.3 Cell Medica Limited Interleukin 17A Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Cell Medica Limited Interleukin 17A Product Portfolio
  18. 6.3.5 Cell Medica Limited Recent Developments
  19. 6.4 Orega Biotech SAS
  20. 6.4.1 Orega Biotech SAS Company Information
  21. 6.4.2 Orega Biotech SAS Business Overview
  22. 6.4.3 Orega Biotech SAS Interleukin 17A Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Orega Biotech SAS Interleukin 17A Product Portfolio
  24. 6.4.5 Orega Biotech SAS Recent Developments
  25. 6.5 AbbVie Inc
  26. 6.5.1 AbbVie Inc Company Information
  27. 6.5.2 AbbVie Inc Business Overview
  28. 6.5.3 AbbVie Inc Interleukin 17A Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 AbbVie Inc Interleukin 17A Product Portfolio
  30. 6.5.5 AbbVie Inc Recent Developments
  31. 6.6 Eli Lilly and Company
  32. 6.6.1 Eli Lilly and Company Company Information
  33. 6.6.2 Eli Lilly and Company Business Overview
  34. 6.6.3 Eli Lilly and Company Interleukin 17A Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Eli Lilly and Company Interleukin 17A Product Portfolio
  36. 6.6.5 Eli Lilly and Company Recent Developments
  37. 6.7 Merck KGaA
  38. 6.7.1 Merck KGaA Company Information
  39. 6.7.2 Merck KGaA Business Overview
  40. 6.7.3 Merck KGaA Interleukin 17A Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Merck KGaA Interleukin 17A Product Portfolio
  42. 6.7.5 Merck KGaA Recent Developments
  43. 6.8 Novartis AG
  44. 6.8.1 Novartis AG Company Information
  45. 6.8.2 Novartis AG Business Overview
  46. 6.8.3 Novartis AG Interleukin 17A Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Novartis AG Interleukin 17A Product Portfolio
  48. 6.8.5 Novartis AG Recent Developments
  49. 6.9 Johnson & Johnson
  50. 6.9.1 Johnson & Johnson Company Information
  51. 6.9.2 Johnson & Johnson Business Overview
  52. 6.9.3 Johnson & Johnson Interleukin 17A Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Johnson & Johnson Interleukin 17A Product Portfolio
  54. 6.9.5 Johnson & Johnson Recent Developments
7 North America by Country
  1. 7.1 North America Interleukin 17A Sales by Country
  2. 7.1.1 North America Interleukin 17A Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Interleukin 17A Sales by Country (2021-2026)
  4. 7.1.3 North America Interleukin 17A Sales Forecast by Country (2027-2032)
  5. 7.2 North America Interleukin 17A Market Size by Country
  6. 7.2.1 North America Interleukin 17A Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Interleukin 17A Market Size by Country (2021-2026)
  8. 7.2.3 North America Interleukin 17A Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Interleukin 17A Sales by Country
  2. 8.1.1 Europe Interleukin 17A Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Interleukin 17A Sales by Country (2021-2026)
  4. 8.1.3 Europe Interleukin 17A Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Interleukin 17A Market Size by Country
  6. 8.2.1 Europe Interleukin 17A Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Interleukin 17A Market Size by Country (2021-2026)
  8. 8.2.3 Europe Interleukin 17A Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Interleukin 17A Sales by Country
  2. 9.1.1 Asia-Pacific Interleukin 17A Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Interleukin 17A Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Interleukin 17A Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Interleukin 17A Market Size by Country
  6. 9.2.1 Asia-Pacific Interleukin 17A Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Interleukin 17A Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Interleukin 17A Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Interleukin 17A Sales by Country
  2. 10.1.1 South America Interleukin 17A Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Interleukin 17A Sales by Country (2021-2026)
  4. 10.1.3 South America Interleukin 17A Sales Forecast by Country (2027-2032)
  5. 10.2 South America Interleukin 17A Market Size by Country
  6. 10.2.1 South America Interleukin 17A Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Interleukin 17A Market Size by Country (2021-2026)
  8. 10.2.3 South America Interleukin 17A Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Interleukin 17A Sales by Country
  2. 11.1.1 Middle East and Africa Interleukin 17A Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Interleukin 17A Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Interleukin 17A Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Interleukin 17A Market Size by Country
  6. 11.2.1 Middle East and Africa Interleukin 17A Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Interleukin 17A Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Interleukin 17A Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Interleukin 17A Value Chain Analysis
  2. 12.1.1 Interleukin 17A Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Interleukin 17A Production Mode & Process
  7. 12.2 Interleukin 17A Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Interleukin 17A Distributors
  10. 12.2.3 Interleukin 17A Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst